0
Precision BioSciences, Inc. Banner Image

Precision BioSciences, Inc.

  • Ticker DTIL
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Precision BioSciences, Inc. Logo Image
  • 201-500 Employees
  • Based in Durham, North Carolina
Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS® genome editing platform. ARCUS is a highly specific and versatile genome editing platform that was designed with therapeutic safety, delivery, and control in mind. Using ARCUS, the Company’s pipeline consists of multiple “off-the-shelf” CAR T immunotherapyMore clinical candidates and several in vivo gene correction therapy candidates to cure genetic and infectious diseases where no adequate treatments exist.
REPORT RATINGS
4.8 / 5.0 (264)

Precision BioSciences, Inc. reports have an aggregate usefulness score of 4.8 based on 264 reviews.

Precision BioSciences, Inc.

Most Recent Annual Report

Precision BioSciences, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Precision BioSciences, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!